Health
Diabetes drug can treat and reverse heart failure and reduce – EurekAlert
Mount Sinai clinical trial results could help lead to FDA approval
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Their clinical trial showed that this medication can improve the heart’s size, shape, and function, leading to better exercise capacity and quality of life, which will reduce hospitalizations for heart failure patients. The results were presented on Friday, November 13, at the American…
-
General21 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Noosa News23 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business21 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General22 hours agoToo skewed, too gentlemanly | The Spectator Australia